HALO

#855
Halozyme Therapeutics, Inc.
69.5300
+1.40%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
69.5300
69.5300
Yıllık aralık
61.2250
82.2200
Günlük değişim
+1.40%
Aylık değişim
-2.00%
6 aylık değişim
+4.09%
Yıllık değişim
+4.09%
Önceki kapanış
68.5700
Open
69.5300
Bid
Ask
Low
69.5300
High
69.5300
Hacim
175
Open full chart

Financials

Overview Rapor Statistics Dividends
Quarterly Annual
  • Market Capitalization 8.3325 B
  • Employee 423
  • Founded 1998
  • CEO Helen I. Torley
  • Website www.halozyme.com
  • Headquarter Delaware, United States
  • FIGI BBG000CZ8W54
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
26.29
Price to sales ratio
5.97
Dividends per share
—
Dividend yield %
—

Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc. is an American biotechnology company. It develops oncology therapies designed to target the tumor microenvironment. The company was founded in 1998 and went public in 2004. Halozyme is headquartered in San Diego, California.

Haberler